Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy

BACKGROUND: This study was designed to evaluate proton magnetic resonance spectroscopy ((1)H-MRS) for monitoring the WHO grade II glioma (low-grade glioma (LGG)) treated with temozolomide (TMZ). METHODS: This prospective study included adult patients with progressive LGG that was confirmed by magnet...

Descripción completa

Detalles Bibliográficos
Autores principales: Guillevin, R, Menuel, C, Taillibert, S, Capelle, L, Costalat, R, Abud, L, Habas, C, De Marco, G, Hoang-Xuan, K, Chiras, J, Vallée, J-N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111204/
https://www.ncbi.nlm.nih.gov/pubmed/21610707
http://dx.doi.org/10.1038/bjc.2011.174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111204/
https://www.ncbi.nlm.nih.gov/pubmed/21610707
http://dx.doi.org/10.1038/bjc.2011.174

Ejemplares similares